ARTICLE | Clinical News
Sovaldi sofosbuvir/velpatasvir: Phase III data
September 28, 2015 7:00 AM UTC
Top-line data from the open-label, U.S. and Puerto Rican Phase III ASTRAL-2 trial in 266 patients with chronic HCV genotype 2 infection showed that a fixed-dose oral combination of once-daily 400 mg S...